Education
About Us
Working with TipRanks
Follow Us
Akeso, Inc. (HK:9926)
:9926
9926 Stock Chart & Stats
HK$110.90
HK$0.30(0.53%)
At close: 4:00 PM EST
HK$110.90
HK$0.30(0.53%)
Day’s Range― - ―
52-Week RangeHK$54.00 - HK$179.00
Previous CloseN/A
Volume3.49M
Average Volume (3M)11.45M
Market Cap
HK$106.12B
Enterprise ValueHK$79.38B
Total Cash (Recent Filing)HK$7.14B
Total Debt (Recent Filing)HK$4.54B
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding921,143,200
10 Day Avg. Volume8,237,327
30 Day Avg. Volume11,452,631
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)7.12
Price to Sales (P/S)22.84
P/FCF Ratio-43.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$187.50Price Target Upside69.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
Clinical TrialsAK112 achieved statistically significant overall survival benefit in the China HARMONi-A study, enhancing the likelihood of global trial success.
Cost EfficiencyAkeso demonstrated improved cost efficiency with selling and R&D expenses as a percentage of product sales shrinking.
Sales GrowthThe NRDL inclusions for Akeso's products, such as AK104 and AK112, have significantly contributed to sales growth.
Bears Say
Akeso, Inc. News
9926 FAQ
What was Akeso, Inc.’s price range in the past 12 months?
Akeso, Inc. lowest stock price was HK$54.00 and its highest was HK$179.00 in the past 12 months.
What is Akeso, Inc.’s market cap?
Akeso, Inc.’s market cap is HK$106.12B.
When is Akeso, Inc.’s upcoming earnings report date?
Akeso, Inc.’s upcoming earnings report date is Apr 01, 2026 which is in 151 days.
How were Akeso, Inc.’s earnings last quarter?
Akeso, Inc. released its earnings results on Aug 26, 2025. The company reported -HK$0.7 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.7.
Is Akeso, Inc. overvalued?
According to Wall Street analysts Akeso, Inc.’s price is currently Undervalued.
Does Akeso, Inc. pay dividends?
Akeso, Inc. does not currently pay dividends.
What is Akeso, Inc.’s EPS estimate?
Akeso, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Akeso, Inc. have?
Akeso, Inc. has 921,143,200 shares outstanding.
What happened to Akeso, Inc.’s price movement after its last earnings report?
Akeso, Inc. reported an EPS of -HK$0.7 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.295%.
Which hedge fund is a major shareholder of Akeso, Inc.?
Currently, no hedge funds are holding shares in HK:9926
Akeso, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$187.50 (69.07% Upside)
HK$187.50 (69.07% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.42%
12-Months-Change
Fundamentals
Return on Equity
-14.40%
Trailing 12-Months
Asset Growth
29.53%
Trailing 12-Months
Company Description
Akeso, Inc.
Akeso, Inc. (9926) is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative antibody drugs for the treatment of cancer, autoimmune diseases, and other serious health conditions. Operating primarily in the biotechnology and pharmaceuticals sectors, Akeso focuses on leveraging its proprietary technology platform to create a diverse pipeline of monoclonal and bispecific antibodies that address unmet medical needs.
9926 Stock 12 Month Forecast
Average Price Target
HK$187.50
▲(69.07% Upside)
Technical Analysis
Sino Biopharmaceutical
―
Innovent Biologics
―
Wuxi Biologics (Cayman)
―
RemeGen Co. Ltd. Class H
―
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Options Prices
Currently, No data available
---